{"id":"W3009494891","doi":"10.1056/nejmoa1904398","title":"Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":565,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Janssen Pharmaceuticals; ViiV Healthcare","keywords":"Rilpivirine; Medicine; Confidence interval; Liter; Clinical endpoint; Internal medicine; Reverse-transcriptase inhibitor; Human immunodeficiency virus (HIV); Integrase inhibitor; Pharmacotherapy; Viral load; Randomized controlled trial; Antiretroviral therapy; Virology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003827214,0.0001369937,0.0005784279,0.00009160642,0.00003237251,0.000003427639,0.00005936014,0.00004246953,0.00009199258],"category_scores_gemma":[0.0006654186,0.00007822465,0.0000629764,0.0001099709,0.00006716722,0.00006236428,0.00001869429,0.000183977,0.000001280513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002343211,"about_ca_system_score_gemma":0.0001179844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008153505,"about_ca_topic_score_gemma":0.000004141058,"domain_scores_codex":[0.9988943,0.0000266728,0.0005112416,0.000119593,0.0002923535,0.0001558293],"domain_scores_gemma":[0.998834,0.0002204519,0.0003298935,0.00007566546,0.0001794412,0.0003605835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01186546,0.0002459835,0.2230913,0.001044958,0.0008100944,0.001142634,0.0141965,0.00002423981,0.03903775,0.0002173344,0.1491315,0.5591923],"study_design_scores_gemma":[0.3327036,0.008752234,0.06128334,0.007047366,0.001892085,0.003248676,0.002557265,0.0009886075,0.03038643,0.000628491,0.5500757,0.0004362205],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.778251,0.003696359,0.01691831,0.1988108,0.0004451473,0.0005339184,0.00001143427,0.0000200471,0.001312972],"genre_scores_gemma":[0.9891814,0.000551135,0.005870401,0.0004698965,0.001783472,0.000001275834,0.00001383954,0.00001672529,0.002111834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5587561,"threshold_uncertainty_score":0.3189909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02603651210254818,"score_gpt":0.2850169726029176,"score_spread":0.2589804605003694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}